Clinical analysis of speculum-based vaginal packing for high-dose-rate intracavitary tandem and ovoid brachytherapy in cervical cancer

被引:6
|
作者
Sud, Shivani [1 ]
Roth, Toni [2 ]
Jones, Ellen [3 ]
机构
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[3] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC USA
关键词
intracavitary brachytherapy; cervical cancer; rectal dose; bladder dose; speculum; retractor; LATE RECTAL COMPLICATIONS; VOLUME PARAMETERS; SPACER BALLOON; CARCINOMA; REDUCTION; RECOMMENDATIONS; RADIOTHERAPY; RETRACTOR; CISPLATIN; TERMS;
D O I
10.5114/jcb.2018.74316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Intra-vaginal packing is used to fix the applicator and displace organs at risk (OAR) during high-doserate intracavitary tandem and ovoid brachytherapy (HDR-ICB). We retain the speculum from applicator placement as a dual-function bladder and rectum retractor during treatment. Our objective is to review salient techniques for OAR displacement, share our packing technique, and determine the reduction in dose to OAR and inter-fraction variability of dose to OAR, associated with speculum-based vaginal packing (SBVP) in comparison to conventional gauze packing during HDR-ICB. Material and methods: We reviewed HDR-ICB treatment plans for 45 patients, including 10 who underwent both conventional gauze packing and SBVP. Due to institutional inter-provider practice differences, patients non-selectively received either packing procedure. Packing was performed under conscious sedation, followed by cone beam computed tomography used for dosimetric planning. Maximum absolute and percent-of-prescription dose to the International Commission of Radiation Units bladder and rectal points in addition to D-0.1cc, D-1.0cc, and D-2.0cc volumes of the bladder and rectum were analyzed and compared for each packing method using an independent sample t-test. Results: Of the 179 fractions included, 73% and 27% used SBVP and gauze packing, respectively. For patients prescribed 6 Gy to point A, SBVP was associated with reduced mean D-0.1cc bladder dose, inter-fraction variability in D-0.1cc bladder dose by 9.3% (p = 0.026) and 9.0%, respectively, and statistically equivalent rectal D-0.1cc, D-1.0cc, and D-2.0cc. Patients prescribed 5.5 Gy or 5 Gy to point A after dose optimization, were less likely to benefit from SBVP. In the intra- patient comparison, 80% of patients had reduction in at least one rectum or bladder parameter. Conclusions: In patients with conducive anatomy, SBVP is a cost-efficient packing method that is associated with improved bladder sparing and comparable rectal sparing relative to gauze packing during HDR-ICB without general anesthesia.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] High-dose-rate brachytherapy using inverse planning optimization with tandem and ovoid applicators for locally advanced cervical cancer: a simulation study
    Yuji Yaegashi
    Kohei Sasaki
    Radiological Physics and Technology, 2021, 14 : 262 - 270
  • [22] A Deep-Learning Approach to Predict Planning Objectives in Cervical Cancer High-Dose-Rate Brachytherapy with a Tandem-And-Ovoid Applicator
    Gonzalez, Y.
    Shen, C.
    Klages, P.
    Albuquerque, K.
    Jia, X.
    MEDICAL PHYSICS, 2018, 45 (06) : E445 - E445
  • [23] A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer
    Sharma, Manju
    Fields, Emma C.
    Todor, Dorin A.
    BRACHYTHERAPY, 2015, 14 (05) : 613 - 618
  • [24] Bladder Filling Reduces Dose to Small Intestines During Intracavitary Tandem and Ovoid Brachytherapy for Cervical Cancer
    Bernstein, M.
    Mehta, K. J.
    Kuo, H.
    Yaparpalvi, R.
    Kalnicki, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S460 - S460
  • [25] Hybrid Intracavitary-Interstitial High-Dose-Rate Brachytherapy for Vaginal Recurrence from Endometrial Cancer
    Kumar, P.
    Gokun, Y.
    Andraos, T.
    Quick, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E698 - E699
  • [26] Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Analysis of dose and fractionation schedule
    Toita, T
    Kakinohana, Y
    Ogawa, K
    Adachi, G
    Moromizato, H
    Nagai, Y
    Maehama, T
    Sakumoto, K
    Kanazawa, K
    Murayama, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (05): : 1344 - 1353
  • [27] Clinical Outcomes for 3D High-Dose-Rate Intracavitary Brachytherapy With MRI-Based Planning for the Treatment of Cervical Cancer
    Gill, B. S.
    Kim, H.
    Houser, C.
    Hosseinzadeh, K.
    Beriwal, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S31 - S31
  • [28] High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
    Kara D. Romano
    Colin Hill
    Daniel M. Trifiletti
    M. Sean Peach
    Bethany J. Horton
    Neil Shah
    Dylan Campbell
    Bruce Libby
    Timothy N. Showalter
    Radiation Oncology, 13
  • [29] High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events
    Romano, Kara D.
    Hill, Colin
    Trifiletti, Daniel M.
    Peach, M. Sean
    Horton, Bethany J.
    Shah, Neil
    Campbell, Dylan
    Libby, Bruce
    Showalter, Timothy N.
    RADIATION ONCOLOGY, 2018, 13
  • [30] Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix
    Eng, TY
    Fuller, CD
    Cavanaugh, SX
    Blough, MM
    Sadeghi, A
    Herman, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 174 - 178